Community Outreach, Mark J. Holterman

IPSAC-VN Improving Vietnamese Healthcare with Scholarship Program



An experienced pediatric surgeon Mark Holterman, MD, has maintained concurrent responsibilities as professor of surgery and pediatrics at the University of Illinois College of Medicine and as CEO of Mariam Global Health for the last five years. An active member of his field, Dr. Mark Holterman supports the work of the International Pediatric Specialists Alliance for the Children of Vietnam (IPSAC-VN).

Since its inception, IPSAC-VN has worked toward the goal of sustainably improving pediatric medicine for the youngest residents of Vietnam. To this end, the organization operates several initiatives that provide medical personnel, supplies, and other needed resources to the region.

IPSAC-VN also supports this need by operating its International Scholar Program, which connects local medical professionals with opportunities to obtain further education at learning institutions in the United States. To qualify for the scholarship, applicants must furnish a letter from their current institution to highlight their dedication to health care improvement.

All IPSAC-VN scholars receive $2,500 to fund their travels to the United States, where they spend up to two months at a host medical institution. During this period, they either train in medical research or participate in clinical examinations. At the close of the scholarship program, participants return to their institution in Vietnam and speak in front of IPSAC-VN supporters. This presentation must cover both their time abroad and the methods they plan to use in their enhancement of local pediatric health care.

Mark J. Holterman, Medical

ADA and CHLA Team Up to Tackle Type 2 Diabetes in Young People


 CHLA pic

A medical school graduate of the University of Virginia, Mark Holterman, MD, teaches surgery and pediatrics at the University of Illinois College of Medicine. Committed to the advancement of medicine and finding a cure for chronic health conditions such as diabetes, Dr. Mark Holterman belongs to the American Diabetes Association (ADA).

In early September, the ADA announced a joint initiative with Children’s Hospital Los Angeles to address the increasing rate of type 2 diabetes occurring in children and teenagers. The two organizations have developed an experience called Camp PowerUp, which utilizes an evidence-based curriculum to engage youth in physical activities and teach them how to make healthier food choices, in order to lower their risk of developing type 2 diabetes.

The program will target young people between the ages of eight and 16 in a range of settings, from day camps and after-school programs to churches and parks. With the experience that the two organizations bring to the table in terms of diabetes care and childhood medicine, they believe programs such as this can help stop the rise of type 2 diabetes in this vulnerable age group.

Community Outreach, Mark J. Holterman

Volunteering with IPSAC-VN



Dr. Mark Holterman, an accomplished medical researcher, practitioner, and educator, splits his time between such roles as professor at the University of Illinois and as CEO of Mariam Global Health. Dedicated to helping patients in a variety of ways, Mark Holterman, MD, supports such charitable organizations as the International Pediatric Specialists Alliance for the Children of Vietnam (IPSAC-VN).

To continue helping healthcare professionals in Vietnam improve access to pediatric surgical care and increase their capacity for such care, IPSAC-VN relies on the support of donors and volunteers.

Volunteers offer the most hands-on support of the organization by providing patient care, training, lecturing, and surgery at affiliate medical schools and hospitals in Vietnam. All volunteers must possess a visa and passport that is valid for at least six months after the date of the trip. In addition to this information, medical volunteers must provide the organization with a copy of their professional license and CV.

Once volunteers are accepted, IPSAC-VN suggests that they purchase travel medicine insurance and recommend that they travel to their determined destination at least two days before they are scheduled to start their volunteering. Team debrief is held before the start date and after the end date, and volunteers are responsible for travel, hotel, and other expenses once in Vietnam.

Mark J. Holterman, Medical

21st Century Cures Act Supports Regenerative Medicine


21st Century Cures Act pic
21st Century Cures Act

Mark Holterman, MD, a pediatric surgeon, has served as a member of the general surgical team at Children’s Hospital at OSF Healthcare since 2011. He is additionally a professor in the Division of Pediatric Surgery at the University of Illinois College of Medicine in Peoria. Dr. Mark Holterman, CEO of regenerative medicine-focused Mariam Global Health, maintains a strong interest in the development of cell-based therapies.

In late 2016, the United States Congress passed and President Obama signed the 21st Century Cures Act. This legislation, the result of bi-partisan alliances in Congress, was designed to help patients with serious health conditions benefit from the fast-tracking of new drugs and medical devices. It also channels new funds into medical research. In addition to its $2 billion designated over a two-year period to fight the American opioid epidemic, and other provisions, the law provides greater support to the field of regenerative medicine.

The act builds on the Food and Drug Administration’s recent practice of incorporating the input of patients into the agency’s drug approval procedures. Thus, it provides for a quicker and more efficient FDA approval process for certain stem cell treatments before they enter the market. The membership of groups such as the World Stem Cell Summit and the Alliance for Regenerative Medicine applauded the new legislation.

Mark J. Holterman, Medical

ADA and APA Join Hands in Training Mental Health Professionals


ADA and APA  pic

Mark Holterman, MD received his degree in medicine and immunology from the University of Virginia. He currently serves as a professor of surgery and pediatrics at the University of Illinois College of Medicine. Dr. Mark Holterman is a member of several professional organizations including the American Diabetes Association (ADA).

Founded in 1940, ADA is a leading non-profit organization that concentrates on conducting research, education, and advocacy activities related to the treatment, prevention, and cure of diabetes. The organization sponsors several programs to support its mission, some of which are collaborative efforts with other organization. One of these programs is the Mental Health Provider Diabetes Education Program, a joint effort with the American Psychological Association.

The program aims to serve the need for mental health professionals who are willing to cater to the psychosocial challenges associated with diabetes management. It is a two-part continuing education program that requires interested practitioners to complete a seven-hour face-to-face seminar and a five-hour online course. Upon successful completion of the courses, providers will be listed on the ADA website which can be freely accessed by those seeking treatment. This program launched in June of this year and has recently received a $839-million grant from the Helmsley Charitable Trust.

Mark J. Holterman, Medical

Treatment Goals for SJIA


Dr. Mark J. Holterman pic
Dr. Mark J. Holterman

Yale University alumnus Mark Holterman, MD is a successful pediatrician and surgeon with over two decades of experience. He currently holds a full professorship position at the University of Illinois College of Medicine where he is an active surgeon inthe division of pediatric surgery. Dr. Mark Holterman was one of the minds behind the establishment of non-profit organization The Hannah Sunshine Foundation.

The Hannah Sunshine Foundation is an organization that focuses on the use of cellular and regenerative therapies for children with rare diseases. It was inspired by three young people, one of which was Sarah Hughes, a 23-year-old woman afflicted with systemic juvenile idiopathic arthritis (SJIA).

SJIA is a serious subtype of juvenile idiopathic arthritis (JIA). Unlike other types of JIA, the condition not only affects the joints but also involves other organs such as the heart, liver, and lungs. The condition is rare and only occurs among 10 to 20 percent of all children who have some form of JIA.

The disease has no known cure as of yet, but treatment is available. Doctors managing the disease focus on achieving permanent remission – a state wherein there are no clinical signs and symptoms that the disease is still active. Due to the damage that it may bring the joints, experts believe that early, aggressive treatment during the active phase of the disease should be encouraged.

Mark J. Holterman, Medical

The American Diabetes Association’s Two Research Awards


American Diabetes Association pic
American Diabetes Association

Mark Holterman, MD, has practiced pediatric surgery and studied regenerative medicine for several years. The CEO of Mariam Global Health, he splits his time between medical research, teaching surgery at the University of Illinois, and providing pediatric care to surgical patients at OSF St. Francis Medical Center. As testament to his successes in the field, Dr. Mark Holterman has earned several awards, including the Innovative Research Award from the American Diabetes Association, an organization committed to funding research into diabetes cures and prevention measures.

The American Diabetes Association offers two research awards to professionals: the Innovative Basic Science (IBS) award and the Innovative Clinical or Translational Science (ICTS) award.

Available to faculty members at any level, the IBS award is given to basic research that presents an innovative and new hypothesis. These hypotheses must be related to the pathophysiology or etiology of diabetes and demonstrate significant progress in terms of advancing diabetes treatment and prevention. The organization specifically encourages high-risk projects that have a larger potential for producing high-impact results.

Eligible applicants are authorized to work in the United States, and IBS award recipients receive up to $115,000 per year for a maximum of three years.

Meanwhile, the ICTS award grants recipients $200,000 per year for up to three years. This award is also limited to professionals who are authorized to work in the country, and it is given to research that presents innovative hypotheses and demonstrates a high probability of high-impact results. However, ICTS award recipient research must directly involve human data, samples, or subjects.